A1 Refereed original research article in a scientific journal
Preterm birth, poor foetal growth and anxiety disorders in a Finnish nationwide register sample
Authors: Ståhlberg Tiia, Upadhyaya Subina, Khanal Prakash, Sucksdorff Minna, Luntamo Terhi, Suominen Auli, Sourander Andre
Publisher: WILEY
Publication year: 2022
Journal: Acta Paediatrica
Journal name in source: ACTA PAEDIATRICA
Journal acronym: ACTA PAEDIATR
Number of pages: 10
ISSN: 0803-5253
DOI: https://doi.org/10.1111/apa.16377
Publication's open availability at the time of reporting: Open Access
Publication channel's open availability : Partially Open Access publication channel
Web address : https://onlinelibrary.wiley.com/doi/epdf/10.1111/apa.16377
Self-archived copy’s web address: https://research.utu.fi/converis/portal/detail/Publication/175437810
Aim: We examined the associations between preterm birth, poor foetal growth and anxiety disorders among children and adolescents. Additionally, we examined the im-pact of common comorbidities and specific anxiety disorders separately.
Methods: Three Finnish registers provided data on a nationwide birth cohort of 22,181 cases with anxiety disorders and 74,726 controls. Conditional logistic regres-sion was used to examine the associations.
Results: Extremely very preterm birth and moderate- late preterm birth were associ-ated with increased adjusted odds ratios (aOR) for anxiety disorders (aOR 1.39, 95% CI 1.11–1.75 and aOR 1.13, 95% CI 1.03–1.23, respectively). Weight for gestational age of less than −2SD (aOR 1.29, 95% CI 1.17–1.42) and −2SD to −1SD (aOR 1.08, 95% CI 1.03–1.14) were associated with increased odds ratios for anxiety disorders. When comorbidities were considered, the associations became statistically insignificant for pure anxiety disorders, but remained significant in the groups with comorbid depres-sive or neurodevelopmental disorders.
Conclusion: Preterm birth and poor foetal growth increased the odds for anxiety dis-orders. However, the associations seem to be explained by the conditions of comorbid depressive and neurodevelopmental disorders. Comorbidities should be considered when examining and treating child and adolescent anxiety disorders.
Downloadable publication This is an electronic reprint of the original article. |